HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiao-Li Lv Selected Research

andrographolide

1/2022URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiao-Li Lv Research Topics

Disease

11Neoplasms (Cancer)
10/2021 - 04/2015
10Glioma (Gliomas)
10/2021 - 04/2016
4Carcinogenesis
01/2018 - 08/2016
3Inflammation (Inflammations)
01/2022 - 01/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2016
3Ovarian Neoplasms (Ovarian Cancer)
04/2016 - 01/2016
2Atherosclerosis
01/2020 - 01/2016
2Lung Neoplasms (Lung Cancer)
01/2016 - 05/2015
1Ischemia
01/2022
1Thyroid Neoplasms (Thyroid Cancer)
01/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
02/2021
1Atherosclerotic Plaque (Atheroma)
01/2020
1Carcinoma (Carcinomatosis)
01/2018
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2018
1Neutropenia
03/2016
1Leukopenia
03/2016
1Ovarian Epithelial Carcinoma
03/2016
1Cardiovascular Diseases (Cardiovascular Disease)
01/2016
1Stomach Neoplasms (Stomach Cancer)
01/2016
1Chronic Hepatitis (Chronic Active Hepatitis)
12/2015
1Breast Neoplasms (Breast Cancer)
06/2015

Drug/Important Bio-Agent (IBA)

11Biomarkers (Surrogate Marker)IBA
10/2021 - 05/2015
7Long Noncoding RNAIBA
01/2022 - 01/2016
6Biological ProductsIBA
01/2020 - 06/2015
4MicroRNAs (MicroRNA)IBA
02/2021 - 01/2017
4Cadherins (E-Cadherin)IBA
01/2020 - 08/2016
2IntegrinsIBA
01/2018 - 03/2017
2PlatinumIBA
03/2016 - 01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
01/2022
1andrographolideIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1Competitive Endogenous RNAIBA
02/2021
1Complement C1s (C1 Esterase)IBA
02/2021
1N-methyladenosineIBA
01/2020
1oil red OIBA
01/2020
1N-formyl-13-dihydrocarminomycin (NFD)IBA
01/2020
1oxidized low density lipoproteinIBA
01/2020
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1Apolipoproteins E (ApoE)IBA
01/2020
1LipidsIBA
01/2020
1CateninsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1IgA receptor (protein B)IBA
01/2017
1Protein Kinases (Protein Kinase)IBA
10/2016
1Proteins (Proteins, Gene)FDA Link
10/2016
1Messenger RNA (mRNA)IBA
10/2016
1vasectrin IIIIBA
04/2016
1taxaneIBA
03/2016
1Cytochrome P-450 CYP3AIBA
03/2016
1Carboplatin (JM8)FDA LinkGeneric
03/2016
1Paclitaxel (Taxol)FDA LinkGeneric
03/2016
1Glycyrrhetinic Acid (Po 12)IBA
12/2015
1Progesterone Receptors (Progesterone Receptor)IBA
06/2015
1Estrogen ReceptorsIBA
06/2015
1phenethyl isothiocyanate (PEITC)IBA
04/2015

Therapy/Procedure

3Therapeutics
01/2017 - 01/2016
2Drug Therapy (Chemotherapy)
01/2016 - 06/2015
1Carotid Endarterectomy
01/2020
1Radiotherapy
01/2017
1Combination Drug Therapy (Combination Chemotherapy)
03/2016
1Neoadjuvant Therapy
06/2015